Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023
Organogenesis Holdings Inc. (Nasdaq: ORGO), a key player in regenerative medicine, will release its first quarter 2023 financial results on May 10th after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Organogenesis Holdings Inc. (Nasdaq: ORGO), a key player in regenerative medicine, will release its first quarter 2023 financial results on May 10th after market close. The company specializes in advanced wound care and surgical and sports medicine solutions. Following the release, management will hold a conference call at 5:00 PM ET to discuss financial results and provide a corporate update. Interested parties can access the live webcast or telephone call through provided links. The archived version will be available on the company’s investor website for one year.
Details
News Market Reaction – ORGO
The recorded move for ORGO in the trading session of this news was -2.29%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CANTON, Mass., April 10, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that first quarter of fiscal year 2023 financial results will be reported after the market closes on Wednesday, May 10th.
Management will host a conference call at 5:00 p.m. Eastern Time on May 10th to discuss the results of the quarter and provide a corporate update with a question and answer session. Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.organogenesis.com. The webcast will be archived on the company website for approximately one year.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.